124 related articles for article (PubMed ID: 32213489)
1. Mouse model of metformin-induced diarrhea.
Takemori H; Hamamoto A; Isogawa K; Ito M; Takagi M; Morino H; Miura T; Oshida K; Shibata T
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32213489
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of glucagon-like peptide-1 and cystic fibrosis transmembrane conductance regulator in the ileum and colon in mouse treated with metformin.
Mizoguchi M; Takemori H; Furukawa S; Ito M; Asai M; Morino H; Miura T; Yabe D; Shibata T
Endocr J; 2023 Feb; 70(2):149-159. PubMed ID: 36198615
[TBL] [Abstract][Full Text] [Related]
3. Aspalathin, a C-glucosyl dihydrochalcone from rooibos improves the hypoglycemic potential of metformin in type 2 diabetic (db/db) mice.
Dludla PV; Gabuza KB; Muller CJF; Joubert E; Louw J; Johnson R
Physiol Res; 2018 Nov; 67(5):813-818. PubMed ID: 30044119
[TBL] [Abstract][Full Text] [Related]
4. Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice.
Mitchell PL; Nachbar R; Lachance D; St-Pierre P; Trottier J; Barbier O; Marette A
Diabetes Obes Metab; 2017 Mar; 19(3):313-319. PubMed ID: 27800648
[TBL] [Abstract][Full Text] [Related]
5. "Metformin-resistant" folic acid producing probiotics or folic acid against metformin's adverse effects like diarrhea.
Olgun A
Med Hypotheses; 2017 Sep; 106():33-34. PubMed ID: 28818268
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with oleanolic acid and metformin as a synergistic treatment for diabetes.
Wang X; Chen Y; Abdelkader D; Hassan W; Sun H; Liu J
J Diabetes Res; 2015; 2015():973287. PubMed ID: 25789330
[TBL] [Abstract][Full Text] [Related]
7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
8. Metformin as a cause of late-onset chronic diarrhea.
Foss MT; Clement KD
Pharmacotherapy; 2001 Nov; 21(11):1422-4. PubMed ID: 11714216
[TBL] [Abstract][Full Text] [Related]
9. Effects of antidiabetic treatment with metformin and insulin on serum and adipose tissue adiponectin levels in db/db mice.
Fujita H; Fujishima H; Koshimura J; Hosoba M; Yoshioka N; Shimotomai T; Morii T; Narita T; Kakei M; Ito S
Endocr J; 2005 Aug; 52(4):427-33. PubMed ID: 16127210
[TBL] [Abstract][Full Text] [Related]
10. Anti-diabetic effects of compound K versus metformin versus compound K-metformin combination therapy in diabetic db/db mice.
Yoon SH; Han EJ; Sung JH; Chung SH
Biol Pharm Bull; 2007 Nov; 30(11):2196-200. PubMed ID: 17978500
[TBL] [Abstract][Full Text] [Related]
11. Diabetes-induced hypomagnesemia is not modulated by metformin treatment in mice.
Kurstjens S; Bouras H; Overmars-Bos C; Kebieche M; Bindels RJM; Hoenderop JGJ; de Baaij JHF
Sci Rep; 2019 Feb; 9(1):1770. PubMed ID: 30742025
[TBL] [Abstract][Full Text] [Related]
12. Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.
Mary A; Hartemann A; Liabeuf S; Aubert CE; Kemel S; Salem JE; Cluzel P; Lenglet A; Massy ZA; Lalau JD; Mentaverri R; Bourron O; Kamel S
Cardiovasc Diabetol; 2017 Feb; 16(1):24. PubMed ID: 28202017
[TBL] [Abstract][Full Text] [Related]
13. Agriophyllum oligosaccharides ameliorate hepatic injury in type 2 diabetic db/db mice targeting INS-R/IRS-2/PI3K/AKT/PPAR-γ/Glut4 signal pathway.
Bao S; Wu YL; Wang X; Han S; Cho S; Ao W; Nan JX
J Ethnopharmacol; 2020 Jul; 257():112863. PubMed ID: 32302715
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics Based on MS in Mice with Diet-Induced Obesity and Type 2 Diabetes Mellitus: the Effect of Vildagliptin, Metformin, and Their Combination.
Tomášová P; Bugáňová M; Pelantová H; Holubová M; Šedivá B; Železná B; Haluzík M; Maletínská L; Kuneš J; Kuzma M
Appl Biochem Biotechnol; 2019 May; 188(1):165-184. PubMed ID: 30393821
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Metformin on Obesity-Induced Dysfunctional Retinas.
Kim AJ; Chang JY; Shi L; Chang RC; Ko ML; Ko GY
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):106-118. PubMed ID: 28114566
[TBL] [Abstract][Full Text] [Related]
16. Metformin induces renal medullary interstitial cell apoptosis in type 2 diabetic mice.
Zheng S; Liu J; Han Q; Huang S; Su W; Fu J; Jia X; Du S; Zhou Y; Zhang X; Guan Y
J Diabetes; 2014 Mar; 6(2):132-46. PubMed ID: 24405721
[TBL] [Abstract][Full Text] [Related]
17. Diarrhea and metformin in a diabetic clinic.
Dandona P; Fonseca V; Mier A; Beckett AG
Diabetes Care; 1983; 6(5):472-4. PubMed ID: 6336343
[TBL] [Abstract][Full Text] [Related]
18. Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation.
Li DJ; Huang F; Lu WJ; Jiang GJ; Deng YP; Shen FM
Acta Physiol (Oxf); 2015 Mar; 213(3):711-21. PubMed ID: 25382002
[TBL] [Abstract][Full Text] [Related]
19. Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma.
Wynn A; Vacheron A; Zuber J; Solomon SS
Am J Med Sci; 2019 Sep; 358(3):200-203. PubMed ID: 31324361
[TBL] [Abstract][Full Text] [Related]
20. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
Hookman P; Barkin JS
Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
